VAX 2012Q
Alternative Names: VAX2012QLatest Information Update: 07 Sep 2017
At a glance
- Originator VaxInnate
- Class DNA vaccines; Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 07 Sep 2017 Discontinued - Phase-I/II for Influenza virus infections (In the elderly, Prevention) in Australia (IM)
- 07 Sep 2017 Discontinued - Phase-II for Influenza virus infections (Prevention) in USA (IM)
- 25 Jun 2015 VaxInnate completes enrolment in its phase II trial for Influenza virus infections (Prevention) in USA (NCT02434276)